Anita Prakash, MD
Cardiovascular Disease (Cardiology) · Brooklyn
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Offices
- 3
Offices
3 locations · New York University · 5,925 clinicians in this group
Hospitals listed: NYU Langone Hospitals. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Prakash’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A84854 · Current
Licensed to practise in California · since 2003 · expires 2027-01-31 · State University of New York at Stony Brook Health Sciences Center.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- NYU Langone HospitalsNew York, NYAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of NYU Langone Health, which runs 5 hospitalsHome of Laura and Isaac Perlmutter Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 11.9 (10.8 to 13.2) · 2,678 cases, Jan 2024 – Dec 2024Better than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.67 (0.56 to 0.78), Jul 2022 – Jun 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 110.18 (84.1 to 136.26) · 561 cases, Jul 2022 – Jun 2024Better than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 2.66 (1.81 to 3.51) · 16,112 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative respiratory failure rate: 3.24 (1.36 to 5.12) · 9,218 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative sepsis rate: 2.56 (1.28 to 3.83) · 9,540 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.39, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.097, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.529, Oct 2024 – Sep 2025Better than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 3.7 (3.1 to 4.4) · 2,678 cases, Jan 2024 – Dec 2024Better than the national rate — Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies): 10.5 (9.1 to 12.3) · 10,521 cases, Jan 2022 – Dec 2024Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.7 to 0.8) · 6,063 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for NYU Langone Hospitals
Behind the star rating — Deaths: 8 better, 0 the same, 0 worse of 8 measures. Safety: 5 better, 2 the same, 1 worse of 8 measures. Readmissions: 8 better, 1 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.9 (10.8 to 13.2) · 2,678 cases | Worse | Jan 2024 – Dec 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.67 (0.56 to 0.78) | Better | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 110.18 (84.1 to 136.26) · 561 cases | Better | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.66 (1.81 to 3.51) · 16,112 cases | Better | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 3.24 (1.36 to 5.12) · 9,218 cases | Better | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 2.56 (1.28 to 3.83) · 9,540 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.39 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.097 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.529 | Better | Oct 2024 – Sep 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 3.7 (3.1 to 4.4) · 2,678 cases | Better | Jan 2024 – Dec 2024 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.5 (9.1 to 12.3) · 10,521 cases | Better | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.7 to 0.8) · 6,063 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.48 (0.95 to 2.01) · 9,995 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 331 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 5.2 · 532 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 6.7 · 547 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 5.2 · 2,910 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 8 · 4,115 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 7.4 · 1,351 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 1.6 · 23,286 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0.01 to 0.24) · 48,461 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.12 to 0.34) · 50,693 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0.66 to 2.11) · 9,390 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.79 (0.99 to 2.59) · 12,979 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.62 (0.53 to 2.72) · 3,510 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.38 to 0.82) · 40,829 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.8 · 3,298 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.091 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.859 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.3 · 667 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.7 · 4,060 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -23.8 · 603 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.8 · 3,334 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.5 · 4,338 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 5,069 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 3.7 · 3,383 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 6.8 · 386 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 820 cases | None | Jul 2023 – Jun 2025 |
What patients said (10,034 patients answered, 23% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$46,616
Medicare paid this office $46,616 for 709 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 51 | $12,483 | $158 |
| Return visit (30+ min) | 55 | $11,798 | $115 |
| New patient visit (60+ min) | 26 | $5,333 | $205 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 577 | $4,967 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 77 | $4,742 | $58 |
See all 7 services
| Long return visit (40+ min) | 51 | $12,483 | $158 |
| Return visit (30+ min) | 55 | $11,798 | $115 |
| New patient visit (60+ min) | 26 | $5,333 | $205 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 577 | $4,967 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 77 | $4,742 | $58 |
| Short return visit (20+ min) | 18 | $1,796 | $86 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 27 | $450 | $13 |
Who their Medicare patients are
709 Original Medicare patients in 2024. Average age 79 · Under 65 4% · 85 and older 31% · Women 53% · Also on Medicaid 20% · Health risk score 1.77. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 46% · Diabetes 38% · Atrial fibrillation 38% · Chronic kidney disease 35% · Heart failure 32% · Depression 29% · Dementia 25% · Cancer 21% · COPD 21% · Stroke 21%.
The office billed $148,714, Medicare allowed $62,690 and paid $46,616; for 1,136 services of 24 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 709 | 1,136 | 79 | 1.77 | $148,714 | $46,616 |
| 2023 | 659 | 1,106 | 80 | 1.83 | $149,643 | $46,461 |
| 2022 | 766 | 1,221 | 79 | 1.76 | $132,792 | $37,498 |
| 2021 | 847 | 1,256 | 79 | 1.83 | $131,152 | $35,525 |
| 2020 | 668 | 981 | 79 | 1.98 | $106,662 | $26,687 |
| 2019 | 666 | 1,017 | 80 | 1.86 | $112,535 | $35,013 |
| 2018 | 626 | 847 | 79 | 1.86 | $79,553 | $21,786 |
| 2017 | 491 | 674 | 79 | 1.96 | $56,112 | $15,919 |
| 2016 | 345 | 447 | 77 | 1.79 | $35,063 | $10,431 |
| 2015 | 248 | 288 | 79 | 2.10 | $17,568 | $2,159 |
| 2013 | 352 | 580 | 78 | 1.99 | $39,444 | $4,778 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Long return visit (40+ min) | 50 | $13,453 | $156 |
| Return visit (30+ min) | 35 | $7,179 | $106 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 541 | $4,825 | $7 |
| New patient visit (60+ min) | 24 | $4,663 | $194 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 77 | $4,635 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $2,465 | $107 |
| Short return visit (20+ min) | 17 | $1,955 | $72 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,719 | $143 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 26 | $411 | $13 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 13 | $167 | $6 |
2022: 10 services
| Long return visit (40+ min) | 35 | $8,480 | $157 |
| Return visit (30+ min) | 31 | $6,182 | $110 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 649 | $6,104 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 76 | $4,852 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $2,762 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,486 | $166 |
| New patient visit (60+ min) | 13 | $2,471 | $190 |
| Short return visit (20+ min) | 11 | $1,047 | $70 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 30 | $282 | $9 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 14 | $213 | $6 |
2021: 7 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 756 | $7,117 | $7 |
| Long return visit (40+ min) | 28 | $6,510 | $163 |
| Return visit (30+ min) | 32 | $6,409 | $100 |
| New patient visit (60+ min) | 28 | $5,563 | $199 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 64 | $4,079 | $59 |
| Short return visit (20+ min) | 19 | $1,742 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $279 | $14 |
2020: 7 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 76 | $5,309 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 572 | $5,166 | $7 |
| Return visit (30+ min) | 32 | $4,758 | $79 |
| Long return visit (40+ min) | 23 | $3,420 | $118 |
| New patient visit (60+ min) | 15 | $2,717 | $181 |
| Short return visit (20+ min) | 19 | $1,188 | $44 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $190 | $15 |
2019: 10 services
| Long return visit (40+ min) | 35 | $6,762 | $130 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 546 | $4,803 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 51 | $3,639 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $3,616 | $90 |
| Critical care, first 30-74 minutes | 16 | $3,613 | $181 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 45 | $2,892 | $60 |
| Return visit (30+ min) | 17 | $2,530 | $101 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,174 | $167 |
| New patient visit (60+ min) | 11 | $1,737 | $158 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 19 | $249 | $6 |
2018: 5 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 552 | $4,709 | $7 |
| New patient visit (60+ min) | 19 | $3,247 | $171 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 40 | $2,406 | $60 |
| Long return visit (40+ min) | 16 | $2,312 | $128 |
| Return visit (30+ min) | 14 | $1,992 | $91 |
2017: 3 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 445 | $3,845 | $7 |
| Return visit (30+ min) | 13 | $1,681 | $88 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 20 | $1,252 | $63 |
2016: 3 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 321 | $2,645 | $7 |
| Long return visit (40+ min) | 11 | $1,852 | $132 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $260 | $16 |
2015: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 248 | $2,159 | $7 |
2013: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 348 | $4,137 | $7 |
Medicaid work
$15,487 in 2024
Medicaid paid $15,487 for 412 billed services this clinician did in 2024, up to 166 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 56 | $14,015 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 356 | $1,472 |
| 2024 | 412 | 2 | 166 | $15,487 |
| 2023 | 378 | 2 | 100 | $11,953 |
| 2022 | 396 | 2 | 97 | $13,877 |
| 2021 | 394 | 1 | 84 | $1,414 |
| 2020 | 288 | 1 | 53 | $2,107 |
| 2019 | 242 | 1 | 68 | $2,076 |
| 2018 | 217 | 1 | 66 | $988 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 50 | $10,684 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 328 | $1,269 |
2022
| Clinic visit/encounter, all-inclusive | 61 | $12,217 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 335 | $1,661 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 394 | $1,414 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 288 | $2,107 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 242 | $2,076 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 217 | $988 |
Drugs they prescribed that Part D paid
$73,906
Pharmacies billed $73,906 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 451) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
398 generic and fewer than 11 brand-name prescriptions · $73,906 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 24 | $32,618 | $1,359 |
| Xarelto | 11 | $10,856 | $987 |
| Metoprolol | 73 | $1,424 | $20 |
| Rosuvastatin | 50 | $670 | $13 |
| Lisinopril | 31 | $337 | $11 |
See all 11 drugs
| Eliquis | 24 | $32,618 | $1,359 |
| Xarelto | 11 | $10,856 | $987 |
| Metoprolol | 73 | $1,424 | $20 |
| Rosuvastatin | 50 | $670 | $13 |
| Lisinopril | 31 | $337 | $11 |
| Atorvastatin | 30 | $334 | $11 |
| Losartan | 31 | $256 | $8 |
| Clopidogrel | 12 | $166 | $14 |
| Simvastatin | 20 | $152 | $8 |
| Amlodipine Besylate | 17 | $131 | $8 |
| Hydrochlorothiazide | 21 | $45 | $2 |
Year by year
| 2024 | 451 | 89 | 0% (0) | None | $73,906 |
| 2023 | 339 | 65 | 0% (0) | None | $44,777 |
| 2022 | 328 | 65 | 0% (0) | 9% | $33,702 |
| 2021 | 258 | 40 | 0% (0) | None | $39,589 |
| 2020 | 173 | 28 | 0% (0) | 12% | $27,946 |
| 2019 | 131 | 27 | 0% (0) | None | $25,500 |
| 2018 | 51 | 14 | 0% (0) | None | $3,728 |
| 2017 | 53 | 11 | 0% (0) | None | $4,743 |
| 2014 | 18 | None | 0% (0) | None | $1,721 |
| 2013 | 338 | 70 | 0% (0) | 17% | $17,927 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Eliquis | 12 | $21,183 | $1,765 |
| Metoprolol | 50 | $1,005 | $20 |
| Lisinopril | 32 | $591 | $18 |
| Atorvastatin | 22 | $411 | $19 |
| Rosuvastatin | 26 | $326 | $13 |
| Losartan | 25 | $212 | $8 |
| Clopidogrel | 14 | $182 | $13 |
| Simvastatin | 17 | $113 | $7 |
| Hydrochlorothiazide | 22 | $112 | $5 |
| Carvedilol | 13 | $85 | $7 |
| Metoprolol | 13 | $56 | $4 |
2022: 11 drugs
| Eliquis | 16 | $26,525 | $1,658 |
| Rosuvastatin | 25 | $675 | $27 |
| Metoprolol | 35 | $622 | $18 |
| Atorvastatin | 33 | $556 | $17 |
| Lisinopril | 26 | $250 | $10 |
| Clopidogrel | 13 | $197 | $15 |
| Losartan | 21 | $153 | $7 |
| Simvastatin | 18 | $149 | $8 |
| Amlodipine Besylate | 17 | $112 | $7 |
| Furosemide | 12 | $108 | $9 |
| Hydrochlorothiazide | 20 | $84 | $4 |
2021: 8 drugs
| Eliquis | 20 | $28,278 | $1,414 |
| Atorvastatin | 21 | $508 | $24 |
| Metoprolol | 23 | $504 | $22 |
| Losartan | 23 | $380 | $17 |
| Lisinopril | 21 | $330 | $16 |
| Simvastatin | 25 | $253 | $10 |
| Carvedilol | 14 | $171 | $12 |
| Hydrochlorothiazide | 17 | $76 | $4 |
2020: 6 drugs
| Eliquis | 13 | $17,350 | $1,335 |
| Metoprolol | 16 | $738 | $46 |
| Atorvastatin | 20 | $398 | $20 |
| Lisinopril | 15 | $336 | $22 |
| Clopidogrel | 13 | $258 | $20 |
| Simvastatin | 21 | $225 | $11 |
2019: 4 drugs
| Eliquis | 15 | $17,036 | $1,136 |
| Metoprolol | 13 | $630 | $48 |
| Simvastatin | 15 | $151 | $10 |
| Lisinopril | 16 | $151 | $9 |
2013: 11 drugs
| Metoprolol | 18 | $2,090 | $116 |
| Clopidogrel | 24 | $1,091 | $45 |
| Warfarin | 36 | $844 | $23 |
| Isosorbide Mononitrate Er | 14 | $529 | $38 |
| Simvastatin | 21 | $299 | $14 |
| Metoprolol | 16 | $234 | $15 |
| Carvedilol | 11 | $214 | $19 |
| Losartan-Hydrochlorothiazide | 12 | $166 | $14 |
| Furosemide | 22 | $119 | $5 |
| Lisinopril | 12 | $105 | $9 |
| Levothyroxine | 15 | $87 | $6 |
Money from drug and device companies
$147 in 2025
| 2025 | 3 | 5 | None | $147 |
| 2024 | 2 | 2 | None | $144 |
| 2023 | 1 | 1 | None | $40 |
| 2022 | 1 | 1 | None | $24 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Merck Sharp & Dohme | Pifeltro | $98 | 3 payments
|
| Otsuka America Pharmaceutical | Rexulti | $26 | 1 payment
|
| ViiV Healthcare | Apretude | $24 | 1 payment
|
See all 5 published payments
| Otsuka America Pharmaceutical | Meals · 2025-12-12 | Rexulti | $26 |
| Merck Sharp & Dohme | Meals · 2025-10-31 | Pifeltro | $34 |
| ViiV Healthcare | Meals · 2025-08-07 | Apretude | $24 |
| Merck Sharp & Dohme | Meals · 2025-05-16 | Pifeltro | $32 |
| Merck Sharp & Dohme | Meals · 2025-03-21 | Pifeltro | $32 |
See earlier years (2024, 2023, 2022)
2024: $144
| Novo Nordisk | None | $122 | 1 payment
|
| Abbvie | Qulipta | $22 | 1 payment
|
2023: $40
| Janssen Pharmaceuticals | Xarelto | $40 | 1 payment
|
2022: $24
| ACADIA Pharmaceuticals | Nuplazid | $24 | 1 payment
|
Professional record
- NPI
- 1578578050
- Licence
- CA A84854California A84854: Current · expires 2027-01-31
- Group
- New York University
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA GR0098530
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 811 Altos Oaks Dr, Suite 2, Los Altos, CA, 94024
- NPI first listed
- 2006-07-30
- NPI last updated
- 2017-03-16
This is when the NPI record was last certified, not a medical board exam.